Optimization of a therapeutic electromagnetic field (EMF) to retard breast cancer tumor growth and vascularity

Ivan L. Cameron, Marko S. Markov, W. Elaine Hardman

Research output: Contribution to journalArticlepeer-review

25 Scopus citations


Background: This study provided additional data on the effects of a therapeutic electromagnetic field (EMF) device on growth and vascularization of murine 16/C mammary adenocarcinoma cells implanted in C3H/HeJ mice. Methods: The therapeutic EMF device generated a defined 120 Hz semi sine wave pulse signal of variable intensity. Murine 16/C mammary adenocarcinoma tumor fragments were implanted subcutaneously between the scapulae of syngeneic C3H mice. Once the tumor grew to 100 mm3, daily EMF treatments were started by placing the cage of mice within the EMF field. Treatment ranged from 10 to 20 milli-Tesla (mT) and was given for 3 to 80 minutes either once or twice a day for 12 days. Tumors were measured and volumes calculated each 3-4 days. Results: Therapeutic EMF treatment significantly suppressed tumor growth in all 7 EMF treated groups. Exposure to 20mT for 10 minutes twice a day was the most effective tumor growth suppressor. The effect of EMF treatment on extent of tumor vascularization, necrosis and viable area was determined after euthanasia. The EMF reduced the vascular (CD31 immunohistochemically positive) volume fraction and increased the necrotic volume of the tumor. Treatment with 15 mT for 10 min/d gave the maximum anti-angiogenic effect. Lack of a significant correlation between tumor CD 31 positive area and tumor growth rate indicates a mechanism for suppression of tumor growth in addition to suppression of tumor vascularization. Conclusion: It is proposed that EMF therapy aimed at suppression of tumor growth and vascularization may prove a safe alternative for patients whether they are or are not candidates for conventional cancer therapy.

Original languageEnglish (US)
Article number125
JournalCancer Cell International
Issue number1
StatePublished - Dec 7 2014


  • Angiogenesis
  • Breast cancer
  • Electromagnetic field (EMF)
  • Endothelial cell marker (CD31)
  • Immunohistochemical

ASJC Scopus subject areas

  • Genetics
  • Oncology
  • Cancer Research


Dive into the research topics of 'Optimization of a therapeutic electromagnetic field (EMF) to retard breast cancer tumor growth and vascularity'. Together they form a unique fingerprint.

Cite this